Occupational Activity – Page 30

Biotech Faces a Reckoning: The Challenges and Shifts in Cell Therapies

1 year ago talkbio0Tagged acceptance, Autoimmune Diseases, Cell Therapy, Drug Industry, gene therapy, Manufacture, Market

cell therapy, biotech, gene therapy, autoimmune diseases, manufacturing challenges, market acceptance, pharmaceutical industry

Eli Lilly Invests $5.3 Billion in Indiana Plant to Boost Diabetes and Obesity Drug Production ###

1 year ago talkbio0Tagged alpha 1-antitrypsin, Diabetes, Eli, Eli Lilly, Glucagon-Like Peptide 1, Indiana, Manufacture, Mounjaro, Nordisk, Obesity, Zepbound

Eli Lilly, Diabetes, Obesity, Mounjaro, Zepbound, Tirzepatide, Indiana, Manufacturing, API, Novo Nordisk, GLP-1 drugs

Unlocking Direct-to-Consumer (DTC) Adoption: Leveraging Telehealth Programs for Enhanced Healthcare Access” ###

1 year ago talkbio0Tagged Adoption, clinical networks, Consumer health, Consumption of goods, Direct-to-Consumer, DTC, Health care facility, perspectives, pharma leaders, Policy, Primary Health Care, Reimbursement models, Services, Telemedicine, virtual care platforms

Direct-to-Consumer (DTC) digital health, Telehealth adoption, Virtual care platforms, Clinical networks, Consumer health and pharma leaders, Telemedicine services, Healthcare consumption, Primary care, Reimbursement models, Policy perspectives

Senior Manager Commercial Analytics Respiratory: Key Requirements and Responsibilities

1 year ago talkbio0Tagged biopharmaceutical industry, commercial, respiratory division, Sales - occupational activity, Senior - Suffix, Strategic Planning, tools

Senior Manager Commercial Analytics Respiratory, biopharmaceutical industry, commercial analytics, therapeutic areas, respiratory division, strategic planning, sales tools.

Ikena Oncology Cuts Hippo Pathway Inhibitor, Lays Off Half of Staff in Strategic Reprioritization

1 year ago talkbio0Tagged Cancer Therapeutic Procedure, Clinical Trials, Hippo Signaling Pathway, Ikena Oncology, Industry, strategic update, TEAD1

Ikena Oncology, Hippo pathway inhibitor, TEAD1-selective, layoffs, strategic update, biotech industry, clinical trials, cancer treatment

James Sabry Departs Roche After 14 Years, Returns to Biotech Industry

1 year ago talkbio0Tagged biotech, career, Drug Industry, genentech, James, Partnering, Roche (company), Sabry

James Sabry, Roche, Genentech, Biotech, Partnering, Pharmaceutical Industry, Career Moves

Revolutionizing CAR-Ts: The Future of Automation and Decentralization in Cell and Gene Therapy Manufacturing

1 year ago1 year ago talkbio0Tagged Advanced therapies, Automation, CAR-Ts, Cells, Decentralization, Digital X-ray, gene therapy, Manufacture, Patient-Centered Care, Precision Medicine, Preventive monitoring, quality management systems, real-time, Regulatory Compliance, Supply chain logistics

Automation, Decentralization, CAR-Ts, Cell and gene therapy manufacturing, Advanced therapies, Personalized medicine, Regulatory compliance, Quality management systems, Supply chain logistics, Digital solutions, Real-time monitoring, Patient-centered care